Warning! GuruFocus detected
4 Severe warning signs
with 50J.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Kangji Medical Holdings Ltd
ISIN : KYG5215A1004
Share Class Description:
FRA:50J: Ordinary SharesCompare
Compare
Traded in other countries / regions
09997.Hong Kong50J.Germany IPO Date
2020-10-13Description
Kangji Medical Holdings Ltd is engaged in the production and sales of minimally invasive surgical instruments and accessories. The principal activities of the Company are to design, develop, manufacture and sell a comprehensive suite of MISIA that are focused on the surgical specialties of OBGYN, urology, general surgery and thoracic surgery. The company offers a product portfolio to provide physicians and hospitals with one-shop and tailored surgical solutions for four surgical specialties OBGYN, general surgery, urology, and thoracic surgery. It manufactures and sells both disposable and reusable products. Its product portfolio includes disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, It derives the majority of its revenue from Mainland China.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 353.57 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 928.43 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 19.2 | |||||
| Beneish M-Score | -1.96 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.1 | |||||
| 3-Year EBITDA Growth Rate | 6 | |||||
| 3-Year EPS without NRI Growth Rate | 7.4 | |||||
| 3-Year FCF Growth Rate | 4.4 | |||||
| 3-Year Book Growth Rate | -10.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 11.93 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 12 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.83 | |||||
| 9-Day RSI | 40.83 | |||||
| 14-Day RSI | 45.3 | |||||
| 3-1 Month Momentum % | 12.41 | |||||
| 6-1 Month Momentum % | 19.85 | |||||
| 12-1 Month Momentum % | 4.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.92 | |||||
| Quick Ratio | 7.5 | |||||
| Cash Ratio | 4.77 | |||||
| Days Inventory | 184.27 | |||||
| Days Sales Outstanding | 86.8 | |||||
| Days Payable | 61.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 21.84 | |||||
| Dividend Payout Ratio | 2.93 | |||||
| 3-Year Dividend Growth Rate | 223.7 | |||||
| Forward Dividend Yield % | 3.69 | |||||
| 5-Year Yield-on-Cost % | 21.84 | |||||
| 3-Year Average Share Buyback Ratio | 1 | |||||
| Shareholder Yield % | 21.84 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 79.08 | |||||
| Operating Margin % | 58.75 | |||||
| Net Margin % | 57.67 | |||||
| FCF Margin % | 50.12 | |||||
| ROE % | 20.02 | |||||
| ROA % | 14.99 | |||||
| ROIC % | 39.68 | |||||
| 3-Year ROIIC % | 4.56 | |||||
| ROC (Joel Greenblatt) % | 113.64 | |||||
| ROCE % | 22.36 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.92 | |||||
| Forward PE Ratio | 12.31 | |||||
| PE Ratio without NRI | 14.78 | |||||
| Price-to-Owner-Earnings | 15.05 | |||||
| PEG Ratio | 1.15 | |||||
| PS Ratio | 8.04 | |||||
| PB Ratio | 3.18 | |||||
| Price-to-Tangible-Book | 3.3 | |||||
| Price-to-Free-Cash-Flow | 16.1 | |||||
| Price-to-Operating-Cash-Flow | 14.49 | |||||
| EV-to-EBIT | 10.34 | |||||
| EV-to-EBITDA | 9.95 | |||||
| EV-to-Revenue | 7.03 | |||||
| EV-to-FCF | 14.07 | |||||
| Price-to-GF-Value | 0.78 | |||||
| Price-to-Projected-FCF | 1.18 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.13 | |||||
| Price-to-Graham-Number | 1.47 | |||||
| Price-to-Net-Current-Asset-Value | 4.58 | |||||
| Price-to-Net-Cash | 9.17 | |||||
| Earnings Yield (Greenblatt) % | 9.67 | |||||
| FCF Yield % | 6.05 | |||||
| Forward Rate of Return (Yacktman) % | 17.01 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kangji Medical Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 130.871 | ||
| EPS (TTM) (€) | 0.064 | ||
| Beta | 1.02 | ||
| 3-Year Sharpe Ratio | 0.03 | ||
| 3-Year Sortino Ratio | 0.04 | ||
| Volatility % | 17.31 | ||
| 14-Day RSI | 45.3 | ||
| 14-Day ATR (€) | 0.025029 | ||
| 20-Day SMA (€) | 0.88025 | ||
| 12-1 Month Momentum % | 4.49 | ||
| 52-Week Range (€) | 0.555 - 0.96 | ||
| Shares Outstanding (Mil) | 1,207.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kangji Medical Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kangji Medical Holdings Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kangji Medical Holdings Ltd Frequently Asked Questions
What is Kangji Medical Holdings Ltd(FRA:50J)'s stock price today?
The current price of FRA:50J is €0.83. The 52 week high of FRA:50J is €0.96 and 52 week low is €0.56.
When is next earnings date of Kangji Medical Holdings Ltd(FRA:50J)?
The next earnings date of Kangji Medical Holdings Ltd(FRA:50J) is .
Does Kangji Medical Holdings Ltd(FRA:50J) pay dividends? If so, how much?
The Dividend Yield %  of Kangji Medical Holdings Ltd(FRA:50J) is 21.84% (As of Today), Highest Dividend Payout Ratio of Kangji Medical Holdings Ltd(FRA:50J) was 2.93. The lowest was 0.11. And the median was 0.41. The  Forward Dividend Yield % of Kangji Medical Holdings Ltd(FRA:50J) is 3.69%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers